Hansen Kosasih

14PUBLICATIONS
44CO-AUTHORS
Haematological tumoursFlight dynamicsNanomedicineMolecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 23, 2026
Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts.

|Jul 16, 2026
OutFOXing a FENDRR bender in T-ALL.

|Feb 19, 2026
IRF2BP2::JAK2 Defines a Novel Kinase-Activating Fusion in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Fatimah B Jalud, Tasnia Ibnat, Kaitlyn Kew

|Aug 11, 2025
Cell surface surprise: NPM1 is an immune therapy target for acute myeloid leukemia.

Hansen J Kosasih, Charles E de Bock

|Nov 08, 2024
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.

Dominik Beck, Honghui Cao, Feng Tian

|Nov 06, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.

Cara E Toscan, Hannah McCalmont, Amir Ashoorzadeh

Pageof 3

Frequent Collaborators

7 joint publications

Charles E de Bock

6 joint publications

Paul G Ekert

5 joint publications

Alicia Oshlack

4 joint publications

Lauren M Brown